| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-05 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-05 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-05 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.0001 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.22 | 0.0001 |